$INMB

$1.52 +$0.09 (6.29%) Close

$INMB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 27.8M shares outstanding

Who owns INMB?

By type of holder

Institutions 15.1% Insiders 10.7% Everyone else 74.2%

Concentration Top 10 holders own 19.1%

Lowdell Mark William 5.5% · Moss David J 4.7%

Institutional ownership

15.1%

-4.3 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

−1.2M

by institutions in Q2 2026

New / sold out

23 / 24

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Aqr Capital Management LLC +391.9K
Millennium Management LLC NEW +159.6K

Biggest sellers in Q2 2026

BlackRock, Inc. −882.5K
Geode Capital Management, LLC −304.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for INmune Bio Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+53.5%

+11.31% a year

Each share's claim on the business

−34.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $36.8M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years38% 3–5 years3% 1–3 years17% Under 1 year42%

Quarterly turnover

36.8%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting INMB on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	311.6K	1.12%	−882.5K (−73.9%)	≤2021	0.0%
Shares held by quarter Peak holding1.2M (Q4'25) Change over 8 quarters−627.9K Share of the company1.120% BlackRock, Inc.'s full portfolio →
VC Vanguard Capital Management LLC	706.4K	2.55%	+19.4K (+2.8%)	≤2021	0.0%
Shares held by quarter Peak holding706.4K (Q2'26) Change over 8 quarters+706.4K Share of the company2.550% Vanguard Capital Management LLC's full portfolio →

BlackRock, Inc.

311.6K

% of company

1.12%

Change vs last qtr

−882.5K (−73.9%)

Held since

≤2021

Vanguard Capital Management LLC

706.4K

% of company

2.55%

Change vs last qtr

+19.4K (+2.8%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding INmune Bio Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INMB on Form N-PORT; together they hold 8.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$799K	490.3K	1.77%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$472K	417.9K	1.51%	0.00%	March 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$799K

% of company

1.77%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$472K

% of company

1.51%

% of the fund

0.00%

As of

March 31, 2026

23 more funds behind a free account

See every fund holding INmune Bio Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LM Lowdell Mark William Insider	1.5M	5.47%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company5.470% Lowdell Mark William's insider activity →
MD Moss David J Insider	1.3M	4.67%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company4.670% Moss David J's insider activity →

Lowdell Mark William

Insider

1.5M

% of company

5.47%

Change vs last qtr

—

Held since

—

Moss David J

Insider

1.3M

% of company

4.67%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of INmune Bio Inc.

Comments